Brief: Anixa Biosciences announces treatment of first patient in its Ovarian Cancer Car-T Clinical Trial
15/08/2022 13:37
Aug 15 (Reuters) - Anixa Biosciences Inc ANIX.O :
* ANIXA BIOSCIENCES ANNOUNCES TREATMENT OF FIRST PATIENT IN
ITS
OVARIAN CANCER CAR-T CLINICAL TRIAL
Source text for Eikon: ID:nPn1m9hNZa
Further company coverage: ANIX.O
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine